Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000371289 | SCV000337590 | uncertain significance | not provided | 2018-07-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086987 | SCV001019670 | likely benign | Bethlem myopathy 1A | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000371289 | SCV001783294 | likely benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004543053 | SCV004792543 | likely benign | COL6A2-related disorder | 2022-02-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |